TreeWAS – Variant ID: rs75900745

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R31 Unspecified haematuria	0.009	0.991	0.000
R17 Unspecified jaundice	0.006	0.994	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.006	0.994	0.000
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.005	0.995	0.000
Z90.7 Acquired absence of genital organ(s)	0.005	0.995	0.000
N39.8 Other specified disorders of urinary system	0.005	0.995	0.000
H93.1 Tinnitus	0.000	0.995	0.005
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.995	0.005
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
B37.0 Candidal stomatitis	0.000	0.996	0.004
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.000	0.997	0.003
R16.1 Splenomegaly, not elsewhere classified	0.003	0.997	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.000	0.997	0.003
B37.8 Candidiasis of other sites	0.000	0.997	0.003
B37.9 Candidiasis, unspecified	0.000	0.997	0.003
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
B37 Candidiasis	0.000	0.997	0.003
H93 Other disorders of ear, not elsewhere classified	0.000	0.997	0.003
K50.8 Other Crohn's disease	0.003	0.997	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
R03.1 Nonspecific low blood-pressure reading	0.000	0.997	0.003
F10.2 Dependence syndrome	0.003	0.997	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.003	0.997	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
K50.1 Crohn's disease of large intestine	0.003	0.997	0.000
K90.0 Coeliac disease	0.003	0.997	0.000
K50.9 Crohn's disease, unspecified	0.003	0.997	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.002	0.997	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.002	0.997	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.002	0.997	0.000
R30-R39 Symptoms and signs involving the urinary system	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
R30.0 Dysuria	0.003	0.997	0.000
E10.1 With ketoacidosis	0.003	0.997	0.000
B37.7 Candidal septicaemia	0.000	0.997	0.002
B37.6 Candidal endocarditis	0.000	0.997	0.002
B37.5 Candidal meningitis	0.000	0.997	0.002
B37.2 Candidiasis of skin and nail	0.000	0.997	0.002
H93.9 Disorder of ear, unspecified	0.000	0.997	0.002
H93.3 Disorders of acoustic nerve	0.000	0.997	0.002
H93.2 Other abnormal auditory perceptions	0.000	0.997	0.002
H93.0 Degenerative and vascular disorders of ear	0.000	0.997	0.002
F10 Mental and behavioural disorders due to use of alcohol	0.003	0.997	0.000
K50 Crohn's disease [regional enteritis]	0.003	0.997	0.000
N80.0 Endometriosis of uterus	0.002	0.998	0.000
B37.1 Pulmonary candidiasis	0.000	0.998	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.002	0.998	0.000
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
F10.0 Acute intoxication	0.002	0.998	0.000
H92.1 Otorrhoea	0.000	0.998	0.002
H93.8 Other specified disorders of ear	0.000	0.998	0.002
G40 Epilepsy	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.000	0.998	0.002
L98.8 Other specified disorders of skin and subcutaneous tissue	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
M54.99 Dorsalgia, unspecified (Site unspecified)	0.002	0.998	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.998	0.002
R30 Pain associated with micturition	0.002	0.998	0.000
M10.9 Gout, unspecified	0.002	0.998	0.000
R39.1 Other difficulties with micturition	0.002	0.998	0.000
G47.9 Sleep disorder, unspecified	0.000	0.998	0.002
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
R39 Other symptoms and signs involving the urinary system	0.002	0.998	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.002	0.998	0.000
F10.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
R04.0 Epistaxis	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
F10.5 Psychotic disorder	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
F10.3 Withdrawal state	0.002	0.998	0.000
L85.9 Epidermal thickening, unspecified	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.000	0.998	0.002
R36 Urethral discharge	0.002	0.998	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.002
F10.8 Other mental and behavioural disorders	0.002	0.998	0.000
F10.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F10.6 Amnesic syndrome	0.002	0.998	0.000
H92 Otalgia and effusion of ear	0.000	0.998	0.002
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
H90-H95 Other disorders of ear	0.000	0.998	0.002
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.000	0.998	0.002
G40.4 Other generalised epilepsy and epileptic syndromes	0.000	0.998	0.002
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.000	0.998	0.002
H47.3 Other disorders of optic disk	0.002	0.998	0.000
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
R30.1 Vesical tenesmus	0.002	0.998	0.000
R34 Anuria and oliguria	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
C62.9 Testis, unspecified	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
G40.8 Other epilepsy	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
R39.2 Extrarenal uraemia	0.002	0.998	0.000
R39.0 Extravasation of urine	0.002	0.998	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.002	0.998	0.000
H52.1 Myopia	0.002	0.998	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.000	0.998	0.002
Y45.1 Salicylates	0.002	0.998	0.000
O97 Death from sequelae of direct obstetric causes	0.002	0.998	0.000
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.002	0.998	0.000
O95 Obstetric death of unspecified cause	0.002	0.998	0.000
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.002	0.998	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.998	0.002
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.000	0.998	0.002
R33 Retention of urine	0.002	0.998	0.000
H40.0 Glaucoma suspect	0.002	0.998	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.002	0.998	0.000
H92.2 Otorrhagia	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
M10.96 Gout, unspecified (Lower leg)	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.000	0.998	0.002
N94.4 Primary dysmenorrhoea	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Z83.5 Family history of eye and ear disorders	0.002	0.998	0.000
H52.2 Astigmatism	0.002	0.998	0.000
J04.0 Acute laryngitis	0.002	0.998	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.000	0.998	0.002
C80.9 Malignant neoplasm, unspecified	0.002	0.998	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.998	0.002
H90.0 Conductive hearing loss, bilateral	0.000	0.998	0.002
H95.1 Other disorders following mastoidectomy	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
M54.94 Dorsalgia, unspecified (Thoracic region)	0.002	0.998	0.000
K90.9 Intestinal malabsorption, unspecified	0.002	0.998	0.000
H52 Disorders of refraction and accommodation	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.000	0.998	0.002
G40.5 Special epileptic syndromes	0.000	0.998	0.001
H02.8 Other specified disorders of eyelid	0.002	0.998	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.998	0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.002	0.998	0.000
R35 Polyuria	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.998	0.000
H49.1 Fourth [trochlear] nerve palsy	0.002	0.998	0.000
N94.3 Premenstrual tension syndrome	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
M54.9 Dorsalgia, unspecified	0.002	0.998	0.000
O96.9 Death from unspecified obstetric cause	0.001	0.998	0.000
O96.1 Death from indirect obstetric cause	0.001	0.998	0.000
O96.0 Death from direct obstetric cause	0.001	0.998	0.000
O97.9 Death from sequelae of obstetric cause, unspecified	0.001	0.998	0.000
O97.1 Death from sequelae of indirect obstetric cause	0.001	0.998	0.000
O97.0 Death from sequelae of direct obstetric cause	0.001	0.998	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.998	0.002
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.002	0.998	0.000
K90 Intestinal malabsorption	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
F10.1 Harmful use	0.002	0.998	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.000	0.998	0.001
H95.8 Other postprocedural disorders of ear and mastoid process	0.000	0.998	0.001
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.000	0.998	0.001
K13.7 Other and unspecified lesions of oral mucosa	0.000	0.998	0.002
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
H52.0 Hypermetropia	0.002	0.998	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.998	0.001
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
R32 Unspecified urinary incontinence	0.002	0.998	0.000
M71.38 Other bursal cyst (Other)	0.001	0.998	0.000
H90.2 Conductive hearing loss, unspecified	0.000	0.998	0.001
N94.5 Secondary dysmenorrhoea	0.001	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
W19.2 School, other institution and public administrative area	0.000	0.998	0.001
H49 Paralytic strabismus	0.002	0.998	0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.000	0.998	0.001
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.998	0.001
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.001
N34.2 Other urethritis	0.001	0.998	0.000
Y91.9 Alcohol involvement, not otherwise specified	0.001	0.998	0.000
H60 Otitis externa	0.000	0.998	0.001
H52.7 Disorder of refraction, unspecified	0.001	0.999	0.000
H72.1 Attic perforation of tympanic membrane	0.000	0.999	0.001
H92.0 Otalgia	0.000	0.999	0.001
R30.9 Painful micturition, unspecified	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.001	0.999	0.000
H49.9 Paralytic strabismus, unspecified	0.001	0.999	0.000
H49.2 Sixth [abducent] nerve palsy	0.001	0.999	0.000
H52.6 Other disorders of refraction	0.001	0.999	0.000
H52.5 Disorders of accommodation	0.001	0.999	0.000
H52.4 Presbyopia	0.001	0.999	0.000
H60.1 Cellulitis of external ear	0.000	0.999	0.001
N94.2 Vaginismus	0.001	0.999	0.000
N94.0 Mittelschmerz	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.001	0.999	0.000
H49.0 Third [oculomotor] nerve palsy	0.001	0.999	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.999	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.001	0.999	0.000
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.001	0.999	0.000
H72.2 Other marginal perforations of tympanic membrane	0.000	0.999	0.001
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.999	0.001
H74.1 Adhesive middle ear disease	0.000	0.999	0.001
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.001	0.999	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.999	0.001
C25.0 Head of pancreas	0.001	0.999	0.000
H47.1 Papilloedema, unspecified	0.001	0.999	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.999	0.001
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.999	0.001
K90.8 Other intestinal malabsorption	0.001	0.999	0.000
K90.3 Pancreatic steatorrhoea	0.001	0.999	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.001	0.999	0.000
K90.1 Tropical sprue	0.001	0.999	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.999	0.001
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.999	0.001
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.999	0.001
H47.7 Disorder of visual pathways, unspecified	0.001	0.999	0.000
H47.6 Disorders of visual cortex	0.001	0.999	0.000
H47.5 Disorders of other visual pathways	0.001	0.999	0.000
H47.4 Disorders of optic chiasm	0.001	0.999	0.000
H49.8 Other paralytic strabismus	0.001	0.999	0.000
H49.4 Progressive external ophthalmoplegia	0.001	0.999	0.000
H49.3 Total (external) ophthalmoplegia	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.001	0.999	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.001	0.999	0.000
E21.2 Other hyperparathyroidism	0.001	0.999	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.999	0.001
H60.5 Acute otitis externa, non-infective	0.000	0.999	0.001
H60.4 Cholesteatoma of external ear	0.000	0.999	0.001
H60.2 Malignant otitis externa	0.000	0.999	0.001
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.001	0.999	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.999	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.001	0.999	0.000
M25.57 Pain in joint (Ankle and foot)	0.001	0.999	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.001	0.999	0.000
D06.9 Cervix, unspecified	0.000	0.999	0.001
Z48.0 Attention to surgical dressings and sutures	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
E10.3 With ophthalmic complications	0.001	0.999	0.000
G40.9 Epilepsy, unspecified	0.000	0.999	0.001
H11.3 Conjunctival haemorrhage	0.001	0.999	0.000
H20.9 Iridocyclitis, unspecified	0.001	0.999	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.001	0.999	0.000
R57.2 Septic shock	0.000	0.999	0.001
C80 Malignant neoplasm without specification of site	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
E10 Insulin-dependent diabetes mellitus	0.001	0.999	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.999	0.001
M81.98 Osteoporosis, unspecified (Other)	0.000	0.999	0.001
H47.2 Optic atrophy	0.001	0.999	0.000
H60.3 Other infective otitis externa	0.000	0.999	0.001
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.999	0.001
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.999	0.001
N64.5 Other signs and symptoms in breast	0.000	0.999	0.001
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y84.0 Cardiac catheterisation	0.000	0.999	0.001
R20 Disturbances of skin sensation	0.000	0.999	0.001
M19.98 Arthrosis, unspecified (Other)	0.001	0.999	0.000
C48.2 Peritoneum, unspecified	0.001	0.999	0.000
H60.8 Other otitis externa	0.000	0.999	0.001
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
E10.2 With renal complications	0.001	0.999	0.000
H74.0 Tympanosclerosis	0.000	0.999	0.001
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
E10.8 With unspecified complications	0.001	0.999	0.000
E10.6 With other specified complications	0.001	0.999	0.000
H51.2 Internuclear ophthalmoplegia	0.001	0.999	0.000
H52.3 Anisometropia and aniseikonia	0.001	0.999	0.000
H60.0 Abscess of external ear	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
M71.34 Other bursal cyst (Hand)	0.001	0.999	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.001	0.999	0.000
C34.3 Lower lobe, bronchus or lung	0.001	0.999	0.000
E10.7 With multiple complications	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y41.0 Sulphonamides	0.001	0.999	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.999	0.001
H70 Mastoiditis and related conditions	0.000	0.999	0.001
H68 Eustachian salpingitis and obstruction	0.000	0.999	0.001
H67 Otitis media in diseases classified elsewhere	0.000	0.999	0.001
F33.0 Recurrent depressive disorder, current episode mild	0.001	0.999	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.999	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.999	0.000
Y47.4 Bromine compounds	0.001	0.999	0.000
Y47.3 Paraldehyde	0.001	0.999	0.000
Y47.2 Chloral derivatives	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000
Y58.4 Tetanus vaccine	0.001	0.999	0.000
Y58.3 Plague vaccine	0.001	0.999	0.000
Y58.2 Cholera vaccine	0.001	0.999	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.999	0.000
Y58.0 BCG vaccine	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
Y59.2 Protozoal vaccines	0.001	0.999	0.000
Y59.1 Rickettsial vaccines	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
K50.0 Crohn's disease of small intestine	0.001	0.999	0.000
R20.1 Hypoaesthesia of skin	0.000	0.999	0.001
R20.0 Anaesthesia of skin	0.000	0.999	0.001
H51 Other disorders of binocular movement	0.001	0.999	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.001	0.999	0.000
C54.1 Endometrium	0.000	0.999	0.001
E10.5 With peripheral circulatory complications	0.001	0.999	0.000
E10.0 With coma	0.001	0.999	0.000
J45.0 Predominantly allergic asthma	0.000	0.999	0.001
K74.3 Primary biliary cirrhosis	0.001	0.999	0.000
M31.6 Other giant cell arteritis	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
Y56.9 Topical agent, unspecified	0.001	0.999	0.000
Y56.8 Other topical agents	0.001	0.999	0.000
Y56.7 Dental drugs, topically applied	0.001	0.999	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.999	0.000
Y56.2 Local astringents and local detergents	0.001	0.999	0.000
Y56.1 Antipruritics	0.001	0.999	0.000
H69 Other disorders of Eustachian tube	0.000	0.999	0.001
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.001	0.999	0.000
H16.9 Keratitis, unspecified	0.001	0.999	0.000
M71.3 Other bursal cyst	0.001	0.999	0.000
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.001	0.999	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.999	0.001
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.999	0.001
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.999	0.001
H68.1 Obstruction of Eustachian tube	0.000	0.999	0.001
H68.0 Eustachian salpingitis	0.000	0.999	0.001
H70.9 Mastoiditis, unspecified	0.000	0.999	0.001
H70.8 Other mastoiditis and related conditions	0.000	0.999	0.001
H70.2 Petrositis	0.000	0.999	0.001
H70.1 Chronic mastoiditis	0.000	0.999	0.001
H70.0 Acute mastoiditis	0.000	0.999	0.001
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.999	0.001
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.999	0.001
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.000	0.999	0.001
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.001	0.999	0.000
M62.88 Other specified disorders of muscle (Other)	0.001	0.999	0.000
H16.0 Corneal ulcer	0.001	0.999	0.000
H51.9 Disorder of binocular movement, unspecified	0.001	0.999	0.000
H51.8 Other specified disorders of binocular movement	0.001	0.999	0.000
H51.1 Convergence insufficiency and excess	0.001	0.999	0.000
H51.0 Palsy of conjugate gaze	0.001	0.999	0.000
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
H73 Other disorders of tympanic membrane	0.000	0.999	0.001
M10 Gout	0.001	0.999	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.999	0.001
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.001	0.999	0.000
H69.0 Patulous Eustachian tube	0.000	0.999	0.001
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
L85 Other epidermal thickening	0.001	0.999	0.000
M71.39 Other bursal cyst (Site unspecified)	0.001	0.999	0.000
M71.37 Other bursal cyst (Ankle and foot)	0.001	0.999	0.000
M71.36 Other bursal cyst (Lower leg)	0.001	0.999	0.000
M71.35 Other bursal cyst (Pelvic region and thigh)	0.001	0.999	0.000
M71.33 Other bursal cyst (Forearm)	0.001	0.999	0.000
M71.32 Other bursal cyst (Upper arm)	0.001	0.999	0.000
M71.31 Other bursal cyst (Shoulder region)	0.001	0.999	0.000
M71.30 Other bursal cyst (Multiple sites)	0.001	0.999	0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.001	0.999	0.000
K72.0 Acute and subacute hepatic failure	0.001	0.999	0.000
L57.0 Actinic keratosis	0.000	0.999	0.001
L85.8 Other specified epidermal thickening	0.001	0.999	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.001	0.999	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.999	0.001
H60-H62 Diseases of external ear	0.000	0.999	0.001
M62.81 Other specified disorders of muscle (Shoulder region)	0.001	0.999	0.000
E10.9 Without complications	0.001	0.999	0.000
H16.2 Keratoconjunctivitis	0.001	0.999	0.000
H43.3 Other vitreous opacities	0.001	0.999	0.000
H69.8 Other specified disorders of Eustachian tube	0.000	0.999	0.001
H73.1 Chronic myringitis	0.000	0.999	0.001
H73.0 Acute myringitis	0.000	0.999	0.001
M10.4 Other secondary gout	0.001	0.999	0.000
M10.3 Gout due to impairment of renal function	0.001	0.999	0.000
M10.2 Drug-induced gout	0.001	0.999	0.000
M10.1 Lead-induced gout	0.001	0.999	0.000
M10.0 Idiopathic gout	0.001	0.999	0.000
R20.3 Hyperaesthesia	0.000	0.999	0.001
W57.8 Other specified place	0.001	0.999	0.000
Y40.3 Macrolides	0.001	0.999	0.000
Z51.4 Preparatory care for treatment, not elsewhere classified	0.000	0.999	0.001
H65 Nonsuppurative otitis media	0.000	0.999	0.001
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
Chapter VIII Diseases of the ear and mastoid process	0.000	0.999	0.001
H34.2 Other retinal artery occlusions	0.001	0.999	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.999	0.001
K85.9 Acute pancreatitis, unspecified	0.001	0.999	0.000
L85.3 Xerosis cutis	0.001	0.999	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.001	0.999	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations